Karuna Therapeutics Stock Price Chart

  • The current trend is moderately bullish and KRTX is experiencing selling pressure, which indicates risk of future bearish movement.

Karuna Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 231.71 Sell
20-day SMA: 226.58 Buy
50-day SMA: 208.52 Buy
200-day SMA: 209.97 Buy
8-day EMA: 230.37 Sell
20-day EMA: 225.44 Buy
50-day EMA: 214.05 Buy
200-day EMA: 196.82 Buy

Karuna Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 56 Buy
Chaikin Money Flow: -269397 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.77 - 231.05) Buy
Bollinger Bands (100): (182.59 - 216.53) Buy

Karuna Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Karuna Therapeutics Stock

Is Karuna Therapeutics Stock a Buy?

KRTX Technical Analysis vs Fundamental Analysis

Karuna Therapeutics (KRTX) is a Buy

Is Karuna Therapeutics a Buy or a Sell?

Karuna Therapeutics Stock Info

Market Cap:
Price in USD:
Share Volume:

Karuna Therapeutics 52-Week Range

52-Week High:
52-Week Low:
Karuna Therapeutics (KRTX) is a Buy

Karuna Therapeutics Share Price Forecast

Is Karuna Therapeutics Stock a Buy?

  • Karuna Therapeutics share price is 227.62 while KRTX 8-day exponential moving average is 230.37, which is a Sell signal.
  • The stock price of KRTX is 227.62 while Karuna Therapeutics 20-day EMA is 225.44, which makes it a Buy.
  • Karuna Therapeutics 50-day exponential moving average is 214.05 while KRTX share price is 227.62, making it a Buy technically.
  • KRTX stock price is 227.62 and Karuna Therapeutics 200-day simple moving average is 196.82, creating a Buy signal.

Fundamental Analysis of Karuna Therapeutics

Is Karuna Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.70 per share, a decrease next quarter of $0.45 per share, a decrease this year of $2.74 per share, and an increase next year of $0.65 per share.

Technical Analysis of Karuna Therapeutics

Should I short Karuna Therapeutics stock?

* Karuna Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.